Sarah Cannon Research Institute Email Format

Research ServicesTennessee, United States501-1000 Employees

Sarah Cannon Research Institute (SCRI), based in Nashville, Tennessee, conducts community-based clinical trials in oncology as part of its research services focus. Over its thirty-year history, SCRI has conducted more than 850 first-in-human trials and contributed to pivotal research that underpins many FDA-approved cancer therapies in the past decade. Its network includes more than 1,300 physicians enrolling patients at over 200 sites across more than 20 states. The organization collaborates with pharmaceutical sponsors and healthcare networks to conduct trials and broaden patient participation. In May 2026, SCRI announced a collaboration with Pfizer Inc. intended to enhance trial execution and patient access.

Sign up for free to view info

Company overview Employee directory